Diabetes Pharmacotherapies and Bladder Cancer: A Medicare Epidemiologic Study
about
Pioglitazone and the Risk of Bladder Cancer: A Meta-Analysis.Comparative safety of pioglitazone versus clinically meaningful treatment alternatives concerning the risk of bladder cancer in older US adults with type 2 diabetes.Pioglitazone and bladder cancer risk: a systematic review and meta-analysis.Pioglitazone use in patients with diabetes and risk of bladder cancer: a systematic review and meta-analysis.
P2860
Diabetes Pharmacotherapies and Bladder Cancer: A Medicare Epidemiologic Study
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Diabetes Pharmacotherapies and Bladder Cancer: A Medicare Epidemiologic Study
@ast
Diabetes Pharmacotherapies and Bladder Cancer: A Medicare Epidemiologic Study
@en
type
label
Diabetes Pharmacotherapies and Bladder Cancer: A Medicare Epidemiologic Study
@ast
Diabetes Pharmacotherapies and Bladder Cancer: A Medicare Epidemiologic Study
@en
prefLabel
Diabetes Pharmacotherapies and Bladder Cancer: A Medicare Epidemiologic Study
@ast
Diabetes Pharmacotherapies and Bladder Cancer: A Medicare Epidemiologic Study
@en
P2093
P2860
P1433
P1476
Diabetes Pharmacotherapies and Bladder Cancer: A Medicare Epidemiologic Study
@en
P2093
Jeremy Smith
Margaret R Karagas
Nancy E Morden
Rebecca Zaha
Todd A Mackenzie
P2860
P2888
P356
10.1007/S13300-016-0152-4
P577
2016-02-19T00:00:00Z